Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study

Not all women diagnosed with PCOS share the same cardiovascular risk profiles

Quality of Life in CKD Patients Treated With Erythropoiesis-Stimulating Agents

Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients

Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation

Do women with PCOS have a unique predisposition to obesity?

Female overweight is not associated with a higher embryo euploidy rate in first trimester miscarriages karyotyped by hysteroembryoscopy

Metformin as a Weight-Loss Tool in “At-Risk” Obese Adolescents: A Magic Bullet?

A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome

The importance of insulin resistance in polycystic ovary syndrome

Long-term consequences of polycystic ovary syndrome on cardiovascular risk

The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome

Expanding the evidence base for the medical treatment of nasal polyposis

Letrozole induction of ovulation in women with clomiphene citrate–resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio